The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA–identical sibling donors: results of the HOVON‐107 study

Author:

Greef Georgine E.1,Braakman Eric1,Holt Bronno2,Janssen Jeroen J.W.M.3,Petersen Eefke4,Vucinic Vladimir5,Thuss Nicole2,Grootes Meriam1,Cornelissen Jan J.1

Affiliation:

1. Department of HematologyErasmus MC Cancer Institute Rotterdam Netherlands

2. Department of HematologyHOVON Data Center. Erasmus MC Rotterdam Netherlands

3. Department of HematologyVU University Hospital Amsterdam Netherlands

4. Department of HematologyUMC Utrecht Utrecht Netherlands

5. Department of Hematology, Clinical Oncology and HemostaseologyUniversity of Leipzig Leipzig Germany

Funder

Sanofi

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Reference28 articles.

1. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation.IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT);Champlin RE;Blood,2000

2. Granulocyte Colony–Stimulating Factor Administration: Adverse Events

3. G-CSF-induced spleen size changes in peripheral blood progenitor cell donors

4. Spontaneous splenic rupture following administration of granulocyte colony ‐stimulating factor therapy in an allogeneic blood stem cell donor;Becker P;Biol Blood Bone Marrow Transplant,1997

5. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3